{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:22:45Z","timestamp":1792221765318,"version":"4.4.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cytokine storm can result from uncontrolled pro-inflammatory cytokines released in SARS-CoV-2 infection that cause damage to several organs. Il-6 is one of the major mediators of cytokine storm. IFN-\u03b12 has been reported to have anti-viral potential and the pre-infection levels of pro-inflammatory cytokines have been suggested to drive the fate of the disease. There is a paucity of information on how anti-viral cytokines at the onset of infection affect the disease progression. This study aims to profile IL-2, IL-6, IL-10, and IFN-\u03b12 expression levels for 44 days post-diagnosis and their effects on recovery. Peripheral venous blood was collected from 38 SARS-CoV-2 infected participants who came for diagnosis at the Centre for Research on Emerging and Re-emerging Diseases. IL-2, IL-6, IL-10, and IFN-\u03b12 levels were measured using a Luminex panel. Males had higher SARS-CoV-2 viral load than females, although the difference was not statistically significant (P = 0.08). Age-related variation was also observed, with individuals aged 40\u201360 showing significantly higher viral load than those over 60 (P = 0.045). Cytokines analysis revealed that males had significantly higher levels of IFN\u03b1-2, IL-2, and IL-6 (P = 0.0031, P = 0.009, and P = 0.022 respectively) than females upon diagnosis, with cytokines levels decreasing over time in males but increasing in females. Cytokine levels trended higher in symptomatic individuals, although differences were not significant. These findings highlight the influence of sex, clinical status, and viral load on cytokine dynamics in COVID-19, with potential implications for understanding disease severity and immune response.<\/jats:p>","DOI":"10.1093\/cei\/uxaf063","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T11:52:11Z","timestamp":1758196331000},"source":"Crossref","is-referenced-by-count":2,"title":["Cytokines dynamics and biological sex differences in SARS-CoV-2 infected people in Cameroon"],"prefix":"10.1093","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0047-6379","authenticated-orcid":false,"given":"Hillary","family":"Tene","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, University of Yaounde I , Yaounde ,","place":["Cameroon"]},{"name":"Immunology Laboratory, The Biotechnology Center, University of Yaounde I , Yaounde ,","place":["Cameroon"]},{"name":"Centre for Research on Emerging and Reemerging Diseases, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation , Yaounde ,","place":["Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romuald","family":"Ngamaleu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, University of Yaounde I , Yaounde ,","place":["Cameroon"]},{"name":"Immunology Laboratory, The Biotechnology Center, University of Yaounde I , Yaounde ,","place":["Cameroon"]},{"name":"Centre for Research on Emerging and Reemerging Diseases, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation , Yaounde ,","place":["Cameroon"]},{"name":"School of Health Sciences, Catholic University of Central Africa , Yaounde ,","place":["Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romeo","family":"Djounda","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, University of Yaounde I , Yaounde ,","place":["Cameroon"]},{"name":"Immunology Laboratory, The Biotechnology Center, University of Yaounde I , Yaounde ,","place":["Cameroon"]},{"name":"Centre for Research on Emerging and Reemerging Diseases, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation , Yaounde ,","place":["Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Minomo","sequence":"additional","affiliation":[{"name":"School of Health Sciences, Catholic University of Central Africa , Yaounde ,","place":["Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Ngale","sequence":"additional","affiliation":[{"name":"School of Health Sciences, Catholic University of Central Africa , Yaounde ,","place":["Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal","family":"Besong","sequence":"additional","affiliation":[{"name":"Immunology Laboratory, The Biotechnology Center, University of Yaounde I , Yaounde ,","place":["Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honore","family":"Awanakam","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, University of Yaounde I , Yaounde ,","place":["Cameroon"]},{"name":"Immunology Laboratory, The Biotechnology Center, University of Yaounde I , Yaounde ,","place":["Cameroon"]},{"name":"Centre for Research on Emerging and Reemerging Diseases, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation , Yaounde ,","place":["Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4839-2886","authenticated-orcid":false,"given":"Krystelle","family":"Nganou-Makamdop","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen , Erlangen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Essomba","sequence":"additional","affiliation":[{"name":"School of Health Sciences, Catholic University of Central Africa , Yaounde ,","place":["Cameroon"]},{"name":"National Public Health Laboratory, Ministry of Health , Yaounde ,","place":["Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Bigoga","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, University of Yaounde I , Yaounde ,","place":["Cameroon"]},{"name":"Immunology Laboratory, The Biotechnology Center, University of Yaounde I , Yaounde ,","place":["Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C","family":"Douek","sequence":"additional","affiliation":[{"name":"Vaccine Research Centre, National Institute of Allergy and Infectious Diseases, Bethesda , Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0793-2826","authenticated-orcid":false,"given":"Forgu","family":"Esemu Livo","sequence":"additional","affiliation":[{"name":"Immunology Laboratory, The Biotechnology Center, University of Yaounde I , Yaounde ,","place":["Cameroon"]},{"name":"Centre for Research on Emerging and Reemerging Diseases, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation , Yaounde ,","place":["Cameroon"]},{"name":"Department of Biomedical Sciences, Faculty of Health Sciences, University of Buea , Buea ,","place":["Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"2025120907362294000_uxaf063-B1","doi-asserted-by":"crossref","first-page":"12272","DOI":"10.3390\/ijms241512272","article-title":"Cytokine kinetics during progression of COVID-19 in Rwanda patients: could IL-9\/IFN\u03b3 ratio predict disease severity?","volume":"24","author":"Ndoricyimpaye","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025120907362294000_uxaf063-B2","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.3390\/ijms24086887","article-title":"Therapeutic effectiveness of interferon-\u03b12b against COVID-19 with community-acquired pneumonia: the Ukrainian experience","volume":"24","author":"Kamyshnyi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025120907362294000_uxaf063-B3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijid.2020.12.014","article-title":"Dynamic anti-spike protein antibody profiles in COVID-19 patients","volume":"103","author":"Bao","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2025120907362294000_uxaf063-B4","doi-asserted-by":"crossref","first-page":"156172","DOI":"10.1016\/j.cyto.2023.156172","article-title":"Type I and III interferons are good markers to monitor COVID-19 pathophysiology","volume":"165","author":"Darif","year":"2023","journal-title":"Cytokine"},{"key":"2025120907362294000_uxaf063-B5","doi-asserted-by":"crossref","first-page":"1273604","DOI":"10.3389\/fimmu.2023.1273604","article-title":"Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection","volume":"14","author":"Mihaescu","year":"2024","journal-title":"Front Immunol"},{"key":"2025120907362294000_uxaf063-B6","doi-asserted-by":"crossref","first-page":"e0120423","DOI":"10.1128\/jvi.01204-23","article-title":"Harnessing the power of IFN for therapeutic approaches to COVID-19","volume":"98","author":"Viox","year":"2024","journal-title":"J Virol"},{"key":"2025120907362294000_uxaf063-B7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12879-023-08294-w","article-title":"Elevated interleukin (IL)-6 as a predictor of disease severity among COVID-19 patients: a prospective cohort study","volume":"23","author":"Nikkhoo","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2025120907362294000_uxaf063-B8","doi-asserted-by":"crossref","first-page":"e06155","DOI":"10.1016\/j.heliyon.2021.e06155","article-title":"IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression","volume":"7","author":"Dhar","year":"2021","journal-title":"Heliyon"},{"key":"2025120907362294000_uxaf063-B9","doi-asserted-by":"crossref","first-page":"200160","DOI":"10.1098\/rsob.200160","article-title":"Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines","volume":"10","author":"Fara","year":"2020","journal-title":"Open Biol"},{"key":"2025120907362294000_uxaf063-B10","doi-asserted-by":"crossref","first-page":"24712","DOI":"10.1038\/s41598-024-75924-x","article-title":"Disease progression associated cytokines in COVID-19 patients with deteriorating and recovering health conditions","volume":"14","author":"Han","year":"2024","journal-title":"Sci Rep"},{"key":"2025120907362294000_uxaf063-B11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cytogfr.2024.08.005","article-title":"Interferon-I modulation and natural products: unraveling mechanisms and therapeutic potential in severe COVID-19","volume":"82","author":"Song","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"key":"2025120907362294000_uxaf063-B12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"2025120907362294000_uxaf063-B13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13054-023-04394-w","article-title":"Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era","volume":"27","author":"Gandini","year":"2023","journal-title":"Crit Care"},{"key":"2025120907362294000_uxaf063-B14","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/MJT.0000000000001603","article-title":"Anakinra-an interleukin-1 receptor antagonist for COVID-19","volume":"30","author":"Nguyen","year":"2023","journal-title":"Am J Ther"},{"key":"2025120907362294000_uxaf063-B15","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with COVID-19","volume":"384","author":"The REMAP-CAP Investigators","year":"2021","journal-title":"N Engl J Med"},{"key":"2025120907362294000_uxaf063-B16","doi-asserted-by":"crossref","first-page":"114533","DOI":"10.1016\/j.celrep.2024.114533","article-title":"Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria","volume":"43","author":"Tapela","year":"2024","journal-title":"Cell Rep"},{"key":"2025120907362294000_uxaf063-B17","author":"Fokam"},{"key":"2025120907362294000_uxaf063-B18","doi-asserted-by":"crossref","first-page":"21654","DOI":"10.1038\/s41598-023-48773-3","article-title":"Genomic surveillance of SARS-CoV-2 reveals highest severity and mortality of delta over other variants: evidence from Cameroon","volume":"13","author":"Fokam","year":"2023","journal-title":"Sci Rep"},{"key":"2025120907362294000_uxaf063-B19","doi-asserted-by":"crossref","first-page":"e0251504","DOI":"10.1371\/journal.pone.0251504","article-title":"Clinical profile and factors associated with COVID-19 in Yaounde, Cameroon: a prospective cohort study","volume":"16","author":"Fouda Mbarga","year":"2021","journal-title":"PLoS One"},{"key":"2025120907362294000_uxaf063-B20","author":"World Health Organisation"},{"key":"2025120907362294000_uxaf063-B21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijregi.2022.05.010","article-title":"Clinical presentation of COVID-19 at the time of testing and factors associated with pre-symptomatic cases in Cameroon","volume":"4","author":"Cyrille","year":"2022","journal-title":"IJID Reg"},{"key":"2025120907362294000_uxaf063-B22","first-page":"209","article-title":"Prevalence of comorbid conditions with aging among patients with diabetes and cardiovascular disease","volume":"70","author":"Davis","year":"2011","journal-title":"Hawaii Med J"},{"key":"2025120907362294000_uxaf063-B23","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","article-title":"Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission","volume":"11","author":"Peckham","year":"2020","journal-title":"Nat Commun"},{"key":"2025120907362294000_uxaf063-B24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/v17040558","article-title":"The association between the Ct value of SARS-CoV-2 and the risk of death from COVID-19 in Amazonas, Peru, during the circulation of the lambda, gamma, and delta variants","volume":"17","author":"Campos","year":"2025","journal-title":"Viruses"},{"key":"2025120907362294000_uxaf063-B25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/vaccines13040431","article-title":"Viral infections in elderly individuals: a comprehensive overview of SARS-CoV-2 and influenza susceptibility, pathogenesis, and clinical treatment strategies","volume":"13","author":"Huang","year":"2025","journal-title":"Vaccines"},{"key":"2025120907362294000_uxaf063-B26","doi-asserted-by":"crossref","first-page":"802228","DOI":"10.3389\/fphar.2022.802228","article-title":"Increased circulating cytokines have a role in COVID-19 severity and death with a more pronounced effect in males: a systematic review and meta-analysis","volume":"13","author":"Hu","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025120907362294000_uxaf063-B27","doi-asserted-by":"crossref","first-page":"e13045","DOI":"10.1016\/j.heliyon.2023.e13045","article-title":"Biological sex and age-related differences shape the antiviral response to SARS-CoV-2 infection","volume":"9","author":"Monta\u00f1o Mendoza","year":"2023","journal-title":"Heliyon"},{"key":"2025120907362294000_uxaf063-B28","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"2025120907362294000_uxaf063-B29","doi-asserted-by":"crossref","first-page":"115595","DOI":"10.1016\/j.diagmicrobio.2021.115595","article-title":"Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: a cohort study","volume":"102","author":"Hagman","year":"2022","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025120907362294000_uxaf063-B30","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1038\/s41598-024-55696-0","article-title":"Severe COVID-19 and long COVID are associated with high expression of STING, cGAS and IFN-\u03b1","volume":"14","author":"Queiroz","year":"2024","journal-title":"Sci Rep"},{"key":"2025120907362294000_uxaf063-B31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12985-021-01597-x","article-title":"Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study","volume":"18","author":"Yin","year":"2021","journal-title":"Virol J"},{"key":"2025120907362294000_uxaf063-B32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10787-022-00992-2","article-title":"COVID-19 and the role of cytokines in this disease","volume":"30","author":"Hasanvand","year":"2022","journal-title":"Inflammopharmacology"},{"key":"2025120907362294000_uxaf063-B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/oalib.1111483","article-title":"Attitudes, and perceptions of COVID-19 vaccines and acceptance to receive COVID-19 vaccine among healthcare workers in Yaounde, Cameroon","volume":"11","author":"Aka","year":"2024","journal-title":"OALib"},{"key":"2025120907362294000_uxaf063-B34","author":"Foudi","year":"2023"},{"key":"2025120907362294000_uxaf063-B35","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxaf063\/64346249\/uxaf063.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf063\/64346249\/uxaf063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf063\/64346249\/uxaf063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:36:30Z","timestamp":1765283790000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxaf063\/8261580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxaf063","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"uxaf063"}}